BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Revenue (Most Recent Fiscal Year) | $2.67B |
Net Income (Most Recent Fiscal Year) | $-637.32M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | 23.78 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 2.99 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.91 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 23.12 |
Pre-Tax Margin (Trailing 12 Months) | -31.82% |
Net Margin (Trailing 12 Months) | -23.86% |
Return on Equity (Trailing 12 Months) | 3.90% |
Return on Assets (Trailing 12 Months) | 2.77% |
Current Ratio (Most Recent Fiscal Quarter) | 5.83 |
Quick Ratio (Most Recent Fiscal Quarter) | 4.34 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.14 |
Inventory Turnover (Trailing 12 Months) | 1.61 |
Book Value per Share (Most Recent Fiscal Quarter) | $306.51 |
Earnings per Share (Most Recent Fiscal Quarter) | -- |
Earnings per Share (Most Recent Fiscal Year) | -- |
Diluted Earnings per Share (Trailing 12 Months) | $-21.49 |
Exchange | NYSE |
Sector | Healthcare |
Industry | Medical Devices |
Common Shares Outstanding | 28.52M |
Free Float | 20.43M |
Market Capitalization | $7.98B |
Average Volume (Last 20 Days) | 91.30 |
Beta (Past 60 Months) | 0.66 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 28.38% |
Percentage Held By Institutions (Latest 13F Reports) | 0.01% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |